Episode 6: Clinical Conversations: Effects of Intermittent Versus Continuous Energy Intakes on Insulin Sensitivity and Metabolic Risk

November 08, 2019 • 00:10:44
Episode 6: Clinical Conversations: Effects of Intermittent Versus Continuous Energy Intakes on Insulin Sensitivity and Metabolic Risk
Obesity: A Disease
Episode 6: Clinical Conversations: Effects of Intermittent Versus Continuous Energy Intakes on Insulin Sensitivity and Metabolic Risk

Nov 08 2019 | 00:10:44

/

Show Notes

Episode Description In this episode, the OMA Chief Science Officer, Dr. Harold Bays, FOMA Dipl. ABOM interviews Nicholas Pennings, DO, FOMA, Dipl. ABOM about Effects of Intermittent Versus Continuous Energy Intakes on Insulin Sensitivity and Metabolic Risk in Women with Overweight and Obesity. Topics covered include: Weight loss benefits of intermittent fasting, compensatory overeating after fasting, effects of intermittent fasting on reduction of muscle mass, and impact on metabolic parameters. You can access more information about Obesity Medicine podcasts and other resources from the clinical leader in Obesity Medicine at www.obesitymedicine.org. Episode Guests Reference Related Resources
Previous Episode
Next Episode

Other Episodes

Episode

October 23, 2025 • 00:25:43
Episode Cover

Episode 121: Endocrine Challenges and Advances in Patients with Obesity

In this sixth episode of our eight part series, Dr. Allison Rhodes welcomes back Dr. Megha Poddar, MD, FRCPC, DABOM, to explore the unique...

Listen

Episode

May 30, 2024 • 00:20:05
Episode Cover

Episode 94: Clinical Conversations: Hunger, Satiety, and Mental Health - A Complex Dance

In this Episode, Obesity Medicine Specialist and OMA Clinical Education Director Dr. Nicholas Pennings interviews, Dr. Carl Knopke, a highlighted speaker from the Obesity...

Listen

Episode 89

January 26, 2024 • 00:16:54
Episode Cover

Episode 89: Article Reviews: Prior Authorizations for Anti-Obesity Medications

In this episode, Dr. Harold Bays and Dr. Carolynn Francavilla discuss their experience with prior authorizations for obesity medications including the highly effective GLP-1...

Listen